Harris, James P.
Burrell, Justin C.
Struzyna, Laura A.
Chen, H. Isaac
Serruya, Mijail D.
Wolf, John A.
Duda, John E.
Cullen, D. Kacy
Article History
Received: 23 May 2017
Accepted: 25 November 2019
First Online: 8 January 2020
Competing interests
: D.K. Cullen is a scientific co-founder and has equity in Innervace, LLC, which is a University of Pennsylvania spin-out company focused on translation of advanced regenerative therapies to treat nervous system disorders. Multiple patents relate to the composition, methods, and use of microtissue-engineered neural networks, including US Patent App. 15/032,677 Neuronal Replacement and Reestablishment of Axonal Connections (D.K.C.), US Patent App. 15/534,934 Methods of Promoting Nervous System Regeneration (D.K.C.), and US Provisional Patent 62/322,434 Implantable Living Electrodes and Methods for Use Thereof (D.K.C., J.P.H., J.A.W., H.I.C., M.D.S.). The authors declare no competing interests.